Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV
NCT00122486
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
1200
Enrollment
OTHER
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
Tenofovir Disoproxil Fumarate
Sponsor
FHI 360